Novartis Reports Data from P-III (STEER) Study of Onasemnogene Abeparvovec to Treat Children and Young Adults with Spinal Muscular...
Shots: The sham-controlled P-III (STEER) trial assessed safety, efficacy & tol...
Sensorion Reports the Completion of Patient Recruitment in P-I/II (Audiogene) Gene Therapy Clinical Trial
Shots: Sensorion has completed patient recruitment for the first cohort (3 patient...
Immunocore Reports the First Patient Dosing with IMC-P115C in P-I Study to Treat Tumors Expressing PRAME
Shots: Immunocore has dosed the first patient with IMC-P115C (PRAME-HLE-A02) under...
Zura Bio Reports Global P-II (TibuSURE) Trial of Tibulizumab to Treat Adults with Systemic Sclerosis
Shots: Zura Bio has reported a global P-II (TibuSURE) trial assessing safety, tole...
Galimedix Therapeutics Commences Pivotal P-II Trial of GAL-101 Eye Drops for Treating Dry AMD
Shots: The pivotal P-II (
